Abudu Ntei, Levinson Stanley S
Warde Medical Laboratory, Ann Arbor, MI, USA.
Clin Chem Lab Med. 2007;45(10):1319-25. doi: 10.1515/CCLM.2007.291.
Most clinical laboratories use calculated (C) low-density lipoprotein cholesterol (LDL-C) for measurement. Some studies have questioned the linearity of CLDL-C in the clinically useful low range. Moreover, it is generally believed that calculation leads to poor precision such that variation in CLDL-C is greater than the 4% guideline since the calculation is dependent on three primary variables. Actually, the degree of variability of a calculated value will be small if the variability of each primary value is small as compared to its contribution to the calculated value. When LDL-C is low, high-density lipoprotein cholesterol (HDL-C), that has poorer precision, becomes more important in defining the precision of CLDL-C. New homogeneous (direct) HDL-C (dHDL) methods show better precision than the older heterogeneous methods. We hypothesized that a direct homogeneous HDL-C method would substantially improve the low range precision of LDL-C as compared to older heterogeneous HDL-C methods.
We compared CLDL-C to a standardized electrophoretic method that shows very high precision. We also compared the precision of CLDL-C calculated using a homogeneous dHDL and a heterogeneous indirect method.
We found good linearity for CLDL-C down to 500 mg/L (x0.002586). The main source of CLDL-C variation was HDL-C. Precision was within guidelines when the dHDL method was used. Using our automated methods for lipoprotein lipids, assuming our reference method is accurate, the formula that calculated CLDL-C (mg/dL) using triglyceride (mg/dL) (x0.001129) x0.2 suggested by some gave more accurate results than the formula using triglyceride (mg/dL) x0.16 suggested by others.
Given the potential for CLDL-C to meet the precision guidelines, until direct LDL-C methods can be refined, CLDL-C should continue to be the primary test used for assessing LDL-C clinically. Standardized testing for CLDL-C for manufacturers should be available so that the formula used for each instrument can provide well-defined accuracy.
大多数临床实验室使用计算得出的(C)低密度脂蛋白胆固醇(LDL-C)进行测量。一些研究对临床有用的低范围内CLDL-C的线性提出了质疑。此外,人们普遍认为计算会导致精密度较差,以至于CLDL-C的变异大于4%的指南要求,因为该计算依赖于三个主要变量。实际上,如果每个主要值的变异与其对计算值的贡献相比很小,那么计算值的变异程度将会很小。当LDL-C较低时,精密度较差的高密度脂蛋白胆固醇(HDL-C)在定义CLDL-C的精密度方面变得更为重要。新的匀相(直接)HDL-C(dHDL)方法比旧的异相方法显示出更好的精密度。我们假设与旧的异相HDL-C方法相比,直接匀相HDL-C方法将显著提高LDL-C在低范围内的精密度。
我们将CLDL-C与显示出非常高精度的标准化电泳方法进行了比较。我们还比较了使用匀相dHDL和异相间接方法计算得出的CLDL-C的精密度。
我们发现CLDL-C在低至500 mg/L(x0.002586)时具有良好的线性。CLDL-C变异的主要来源是HDL-C。使用dHDL方法时精密度在指南范围内。使用我们的脂蛋白脂质自动化方法,假设我们的参考方法准确,一些人建议的使用甘油三酯(mg/dL)(x0.001129)x0.2来计算CLDL-C(mg/dL)的公式比其他人建议的使用甘油三酯(mg/dL)x0.16的公式给出了更准确的结果。
鉴于CLDL-C有满足精密度指南的潜力,在直接LDL-C方法能够完善之前,CLDL-C应继续作为临床上评估LDL-C的主要检测方法。应为制造商提供CLDL-C的标准化检测,以便用于每种仪器的公式能够提供明确的准确性。